Is total body irradiation a necessary component of preparative therapy for autologous transplantation in non-Hodgkin's lymphoma

Leukemia and Lymphoma

Volumn 41, Issue 1-2, 2001, Pages 97-103

  Stein, R S ^a   Greer, J P ^a   Goodman, S ^a   Brandt, S J ^a   Morgan, D S ^a   Macon, W R ^a   McCurley, T L ^a   Wolff, S N ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIBIOTIC AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; AGE; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW DISEASE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FATALITY; FEMALE; GENDER; HEMATOPOIETIC STEM CELL; HISTOLOGY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SALVAGE THERAPY; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 0035072522     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109057958     Document Type: Article

References (18)

1. Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous bone marrow
2. High dose therapy and autologous marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high grade non-Hodgkin's lymphoma
3. Prolonged disease free survival after autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high grade non-Hodgkin's lymphoma with a poor prognosis
4. Bone marrow transplantation in the treatment of patients with lymphoma
5. Which patients with relapsed non-Hodgkin's lymphoma benefit from high dose therapy and hematopoietic stem cell transplantation?
6. Feasibility of autologous transplantation for early consolidation of follicular non-Hodgkin's lymphoma
7. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma
8. High dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission
9. Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: A case matched comparison with unpurged cases by the European blood and marrow transplant lymphoma registry
10. Value of autologous bone marrow transplantation in follicular lymphoma: A France Autogreffe retrospective study of 42 patients
11. High dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin
12. Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade lymphoma
13. Limited efficacy of intensified preparative regimens in autologous transplantation as salvage therapy in high grade non-Hodgkin's lymphoma
14. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose ARA-C and dexamethasone (DHAP)
15. ESHAP- An effective chemotherapy regimen in refractory and relapsing lymphoma: A 4-year follow-up study
16. Non parametric estimation from incomplete observations
17. High dose therapy with autologous hematopoietic rescue for follicular low grade non-Hodgkin's lymphoma
18. High-dose therapy and autologous stem cell transplantation (ASCT) for poor risk and relapsed non-Hodgkin's lymphoma (NHL): Long term follow-up results and analysis of prognostic factors in 369 patients